Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05628194 · ClinicalTrials.gov registry record
Assessing THE GAY Male Experience With Anal Cancer Prevention Strategies
A clinical trial of Anal Cancer, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT05628194: Recruiting study of Anal Cancer, sponsored by University of Minnesota.
NCT05628194 is a study of Anal Cancer that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 5,000 participants, above the 317-participant average among 19 other Anal Cancer trials with a reported enrollment target (1477% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05628194, a study of Anal Cancer, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to describe current knowledge and opinions about anal cancer screening among men who have sex with men (MSM), as well as their experience receiving guideline-compliant care aimed at anal cancer risk reduction using a large-scale survey disseminated via social media.
Primary Outcome
Survey with question items on participants' awareness of anal cancer risk
Conditions Studied
Interventions
- OTHER Observational/Survery
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2023-06-08 |
| Est. Completion | 2026-06-30 |
What NCT05628194 shows while recruiting
NCT05628194 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 317-participant average among 19 other Anal Cancer trials with a reported enrollment target (1477% higher).
The record links to 1 condition, with Anal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Observational/Survery is the first listed.
NCT05628194 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05628194 about?
NCT05628194 is a clinical study titled "Assessing THE GAY Male Experience With Anal Cancer Prevention Strategies". The purpose of this study is to describe current knowledge and opinions about anal cancer screening among men who have sex with men (MSM), as well as their experience receiving guideline-compliant care aimed at anal cancer risk reduction using a large-scale survey disseminated via social media.
What is the current status of trial NCT05628194?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2023-06-08. Estimated completion is 2026-06-30.
What conditions does trial NCT05628194 study?
This clinical trial studies the following conditions: Anal Cancer.
What interventions are being tested in trial NCT05628194?
The interventions under investigation include: Observational/Survery (OTHER).
Who is sponsoring clinical trial NCT05628194?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05628194 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05628194's enrollment target sits among peer trials
5,000 1st of 19 higher than 19 of 19 other Anal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Self-sampling to Optimize Anal Lesion Outcomes
RECRUITING · NA
-
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
RECRUITING · Phase 2
-
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
RECRUITING
-
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
RECRUITING · Phase 2
-
Integrated Cancer Repository for Cancer Research
RECRUITING
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI